Completed
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects
NCT03155503
- Conditions
- Behavior, Behavioral Symptoms, Depression, +4 more
- Locations
-
- QuintilesIMS Phase 1 Services, LLC Kansas City, Kansas, United States